Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
- Status
- TERMINATED
- Phase
- PHASE2
Oxaliplatin and Topotecan in Advance Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.
- Status
- COMPLETED
- Phase
- PHASE3
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Oxaliplatin in Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin and 5-FU Based Preoperative Chemoradiation
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
- Status
- UNKNOWN
- Phase
- PHASE2